AI and Cell Therapy Intersect to Revolutionize the Biopharma Industry

 

Artificial intelligence (AI) is often associated with consumer-facing and mainstream industries such as gaming, securities and retail, but it plays just as crucial of a role in the biopharma industry. Sandi Colner, head of lab and life sciences vertical for Intel, and Stephanie Davies, head of science for cell therapy at ValitaCell, joined Host Tyler Kern to discuss this.

“The reason these therapies are important is that they really are a potential solution for a lot of diseases that don’t have alternative treatments like certain types of cancer, or OA and Crohn’s disease,” Davies explained.

Currently, the manufacturing process is still crude. This is partly because tools to monitor cell health and function can take half the time the entire process takes. Embedding a new breed of simple, automatable analytics in these processes — such as image and AI based assessment of cell quality — can help produce a high yield of quality cells to treat patients. This can help decrease the strenuous manufacturing processes that limit the industry.

Sandi Colner, head of Lab and Life Sciences at Intel says that the biopharmaceutical industry is undergoing an immense digital transformation driven by AI. “Although the application of AI in manufacturing is still in its nascent stage,” Colner says, “it’s already created an extensive ecosystem of different AI solution providers.”

Davies believes the key to accelerating this lies in industry collaboration. “I think these amazing collaborations that we are having across various parts of the industry are going to help connect different siloed data sets. It’s going to enable us to have access to sufficiently large data sets that are diverse and that are really going to be needed to train these AI models,” she said.

Looking to the future both Davies and Colner see many ways AI can help solve problems in the emerging cell and gene therapy industry. “This is difficult science, and we need to acknowledge that,” says Colner. She continues to explain that the next collaborations happening across various parts of the AI industry will enable new cell therapies to be delivered.

If you are interested in learning more or collaborating in the transformation of the biopharma industry, please connect with Stephanie Davies or Sandi Colner on LinkedIn.

Subscribe to the “Health and Life Sciences at the Edge” channel on Apple PodcastsSpotifyGoogle Podcasts, or Simplecast to hear more from the Intel Internet of Things Group.

Follow us on social media for the latest updates in B2B!

Image

Latest

community building
Community Building Through Marketing—Powered by Showing Up and Staying Open
July 1, 2025

In this episode of Professional Quotient: Conversations That Build Equity, host Jason Winningham sits down with Alicia Layfield, founder of Casa Layfield, a boutique marketing agency in Houston, Texas. Alicia shares how she built her business from the ground up—not by following a perfect plan, but by showing up, staying open, and turning connections…

Read More
Class 8 trucks
Driving the Future at ACT Expo: Windrose Showcases Its Purpose-Built Electric Class 8 Trucks
July 1, 2025

At the ACT Expo, Hammer Down host Mike Bush dives deeper into the future of freight with a hands-on look at Windrose Technology’s electric Class 8 trucks. Joined by Joseph Jaramillo, Driver Supervisor at Talon Logistics, Mike takes a test drive to experience the smooth ride, dual digital displays, and unique features—like advanced regen modes and a…

Read More
ball valve
Zero-Friction Flow: Trillium Launches the Red Point® Non-Contact Rising Stem Ball Valve to Cut Downtime, Boost Safety, and Perform in Demanding Applications
June 30, 2025

Join host Michelle Dawn Mooney for this special episode of FlowCast by Trillium Flow Technologies, as she sits down with Fred Jansen, General Manager of Trillium’s Netherlands facility, and Pepijn Esman, Engineering Manager for Red Point, to unveil the non-contact Rising Stem Ball Valve (RSBV)—a breakthrough engineered for extreme-service applications across oil &…

Read More
student success
The AI-Powered Edge in Education: How LearningClues Is Enabling Student Success with Co-founder and CEO Dr. Perry Samson
June 30, 2025

As AI continues to reshape education, institutions face a growing challenge in ensuring students succeed without compromising engagement or integrity. Today’s college students are often juggling jobs, family, and coursework, leading to limited study time and increased dropout risk. According to the National Center for Education Statistics, 40% of full-time undergraduates and 74% of…

Read More